Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H2, 2014" provides data on the Cytomegalovirus (CMV) Retinitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cytomegalovirus (CMV) Retinitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cytomegalovirus (CMV) Retinitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe,... Research Beam Model: Research Beam Product ID: 153552 2500 USD New
Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H2, 2014

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H2, 2014

 
  • Category : Pharmaceuticals
  • Published On : November  2014
  • Pages : 66
 
 
Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H2, 2014" provides data on the Cytomegalovirus (CMV) Retinitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cytomegalovirus (CMV) Retinitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cytomegalovirus (CMV) Retinitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Cytomegalovirus (CMV) Retinitis 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Europe 8
Top Countries Contributing to Clinical Trials in North America 9
Clinical Trials by G7 Countries: Proportion of Cytomegalovirus (CMV) Retinitis to Infectious Disease Clinical Trials 10
Clinical Trials by Phase in G7 Countries 11
Clinical Trials in G7 Countries by Trial Status 12
Clinical Trials by Phase 13
Clinical Trials by Trial Status 14
Clinical Trials by End Point Status 15
Unaccomplished Trials of Cytomegalovirus (CMV) Retinitis 16
Clinical Trials by Sponsor Type 17
Prominent Sponsors 18
Top Companies Participating in Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials 19
Prominent Drugs 20
Clinical Trial Profiles 21
Clinical Trial Overview of Top Companies 21
F. Hoffmann-La Roche Ltd. 21
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 21
Novartis AG 23
Clinical Trial Overview of Novartis AG 23
Isis Pharmaceuticals, Inc. 24
Clinical Trial Overview of Isis Pharmaceuticals, Inc. 24
AstraZeneca PLC 25
Clinical Trial Overview of AstraZeneca PLC 25
Gilead Sciences, Inc. 26
Clinical Trial Overview of Gilead Sciences, Inc. 26
Roche Global Development 27
Clinical Trial Overview of Roche Global Development 27
Pfizer Inc. 28
Clinical Trial Overview of Pfizer Inc. 28
Merck & Co., Inc. 29
Clinical Trial Overview of Merck & Co., Inc. 29
Astra AB 30
Clinical Trial Overview of Astra AB 30
Clinical Trial Overview of Top Institutes / Government 31
The National Institute of Allergy and Infectious Diseases 31
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 31
National Eye Institute 32
Clinical Trial Overview of National Eye Institute 32
The American National Red Cross 33
Clinical Trial Overview of The American National Red Cross 33
Medical University of Vienna 34
Clinical Trial Overview of Medical University of Vienna 34
University Hospital Basel 35
Clinical Trial Overview of University Hospital Basel 35
National Center for Research Resources 36
Clinical Trial Overview of National Center for Research Resources 36
National Cancer Institute 37
Clinical Trial Overview of National Cancer Institute 37
National Heart, Lung, and Blood Institute 38
Clinical Trial Overview of National Heart, Lung, and Blood Institute 38
Five Key Clinical Profiles 39
Appendix 64
Abbreviations 64
Definitions 64
Research Methodology 65
Secondary Research 65
About GlobalData 66
Contact Us 66
Disclaimer 66
Source 66
List Of Tables
List of Tables
Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials by Region, 2014* 6
Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Europe, Top Countries, 2014* 8
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, North America, Top Countries, 2014* 9
Proportion of Cytomegalovirus (CMV) Retinitis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 10
Cytomegalovirus (CMV) Retinitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 11
Cytomegalovirus (CMV) Retinitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 12
Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials by Phase, 2014* 13
Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 14
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 15
Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 16
Cytomegalovirus (CMV) Retinitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 17
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 18
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 19
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 20
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 21
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 23
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Isis Pharmaceuticals, Inc., 2014* 24
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 25
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014* 26
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Roche Global Development, 2014* 27
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 28
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 29
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Astra AB, 2014* 30
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 31
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2014* 32
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The American National Red Cross, 2014* 33
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014* 34
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014* 35
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014* 36
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 37
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 38
List Of Figures
List of Figures
Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 8
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 9
Proportion of Cytomegalovirus (CMV) Retinitis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 10
Cytomegalovirus (CMV) Retinitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 11
Cytomegalovirus (CMV) Retinitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 12
Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 13
Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 14
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 15
Cytomegalovirus (CMV) Retinitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 17
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 18
Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 19
GlobalData Methodology 65